- Ophthalmic Surgery, Lasers and Imaging
- July/August 2012 - Volume 43 · Issue 4: 311-318
BACKGROUND AND OBJECTIVE:
To present the clinical outcomes of the Neusidl Corneal Inserter (NCI) (Fischer Surgical, Imperial, MO), a new donor inserter for Descemet’s stripping automated endothelial keratoplasty (DSAEK).
PATIENTS AND METHODS:
Six eyes of 6 Japanese patients (mean age = 74.0 years) with endothelial dysfunction were enrolled in this prospective, non-comparative study. All patients had a small cornea of 9.0 mm or less in diameter. A donor was inserted into the eye using NCI. Intraoperative and postoperative complications, postoperative donor endothelial cell densities (ECD), and best-corrected visual acuity (BCVA) were evaluated.
Donor loading onto NCI was successful in all cases. No intraoperative or postoperative complications were noted. All cases reached more than 20/63 BCVA within 12 months. Mean ECD was 2,441 cells/mm2 (mean loss = 22.1%) at 6 months and 2,159 cells/mm2 (mean loss = 31.0%) at 12 months.
Graft insertion with NCI is safe in DSAEK with low endothelial cell loss.
From the Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
Presented at the 81th Association for Research in Vision and Ophthalmology meeting; May 2, 2010; Fort Lauderdale, Florida.
Supported by a grant from Intractable Disease Treatment Research Program (10103447), the Ministry of Health, Labour and Welfare, Japan, and Grant-in-Aid for Scientific Research (C) KAKENHI, Japan (No. 22591934).
The authors have no financial or proprietary interest in the materials presented herein.
Address correspondence to Akira Kobayashi, MD, PhD, Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, 13-1 Takaramachi, Kanazawa-shi, Ishikawa-ken 920-8641 Japan. E-mail: email@example.com
Received: January 31, 2012
Accepted: March 18, 2012
Posted Online: May 03, 2012